Integrated Wealth Concepts LLC Purchases 4,341 Shares of The Clorox Company (NYSE:CLX)

Integrated Wealth Concepts LLC boosted its holdings in The Clorox Company (NYSE:CLX - Free Report) by 46.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,756 shares of the company's stock after acquiring an additional 4,341 shares during the quarter. Integrated Wealth Concepts LLC's holdings in Clorox were worth $2,234,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Vanguard Group Inc. increased its stake in Clorox by 0.8% during the 4th quarter. Vanguard Group Inc. now owns 15,507,152 shares of the company's stock valued at $2,518,517,000 after purchasing an additional 124,428 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of Clorox by 2.3% during the fourth quarter. Geode Capital Management LLC now owns 3,098,302 shares of the company's stock worth $501,925,000 after purchasing an additional 69,969 shares in the last quarter. Stifel Financial Corp increased its holdings in shares of Clorox by 0.4% in the 4th quarter. Stifel Financial Corp now owns 2,344,408 shares of the company's stock valued at $380,761,000 after acquiring an additional 9,582 shares during the period. Norges Bank acquired a new position in shares of Clorox during the fourth quarter worth about $259,041,000. Finally, FMR LLC increased its position in shares of Clorox by 75.4% in the fourth quarter. FMR LLC now owns 1,361,758 shares of the company's stock valued at $221,163,000 after buying an additional 585,526 shares in the last quarter. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Stock Performance

Shares of Clorox stock traded down $3.78 during midday trading on Thursday, hitting $138.52. The company had a trading volume of 1,812,846 shares, compared to its average volume of 1,306,293. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.37. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The stock has a market cap of $17.06 billion, a PE ratio of 37.85, a P/E/G ratio of 2.62 and a beta of 0.61. The business's 50 day simple moving average is $144.83 and its two-hundred day simple moving average is $155.29.

Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping analysts' consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter last year, the firm posted $2.16 earnings per share. As a group, equities analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be paid a $1.22 dividend. The ex-dividend date is Wednesday, April 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.52%. Clorox's payout ratio is currently 133.33%.

Analyst Ratings Changes

CLX has been the subject of a number of analyst reports. JPMorgan Chase & Co. decreased their price target on Clorox from $173.00 to $151.00 and set a "neutral" rating for the company in a report on Friday, April 11th. Evercore ISI lifted their price objective on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. DA Davidson lowered their target price on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a report on Wednesday, February 5th. Wells Fargo & Company cut their price target on shares of Clorox from $155.00 to $145.00 and set an "equal weight" rating on the stock in a research report on Wednesday, April 16th. Finally, StockNews.com downgraded shares of Clorox from a "buy" rating to a "hold" rating in a report on Sunday, January 5th. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Hold" and an average target price of $153.83.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.